2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Sunday, November 5, 2017

9:00AM-11:00AM: Antiphospholipid Syndrome Poster

9:00AM-11:00AM: ARHP Education Poster

9:00AM-11:00AM: ARHP Health Services Research Poster

9:00AM-11:00AM: ARHP Healthcare Disparities in Rheumatology Poster

9:00AM-11:00AM: ARHP Orthopedics, Low Back Pain and Rehabilitation Poster

9:00AM-11:00AM: ARHP Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster

9:00AM-11:00AM: B Cell Biology and Targets in Autoimmune Disease Poster

9:00AM-11:00AM: Biology and Pathology of Bone and Joint Poster I

9:00AM-11:00AM: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster I: The Variable World of Intercellular Signalling

9:00AM-11:00AM: Education Poster

9:00AM-11:00AM: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

9:00AM-11:00AM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

9:00AM-11:00AM: Genetics, Genomics and Proteomics Poster I

9:00AM-11:00AM: Health Services Research Poster I

9:00AM-11:00AM: Healthcare Disparities in Rheumatology Poster

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster I

9:00AM-11:00AM: Infection-related Rheumatic Disease Poster

9:00AM-11:00AM: Innate Immunity and Rheumatic Disease Poster I

9:00AM-11:00AM: Orthopedics, Low Back Pain and Rehabilitation Poster

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster I

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster I

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster I: Autoinflammatory Disorders and Miscellaneous

9:00AM-11:00AM: Rheumatoid Arthritis – Animal Models Poster I

9:00AM-11:00AM: Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response

9:00AM-11:00AM: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster I: Comorbidities and Adverse Events; Efficacy and Safety of Small Molecules

9:00AM-11:00AM: Sjögren's Syndrome Poster I: Translational Research

9:00AM-11:00AM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster I

9:00AM-11:00AM: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster I

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster I

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster I

9:00AM-11:00AM: Vasculitis Poster I: Large Vessel Vasculitis

11:00AM-12:30PM: Plenary Session I

2:30PM-4:00PM: ARHP Psychosocial Impact on Rheumatic Disease

2:30PM-4:00PM: B Cell Biology and Targets in Autoimmune Disease

2:30PM-4:00PM: Epidemiology and Public Health I: Lung, Bone, and Infection Outcomes

2:30PM-4:00PM: Muscle Biology, Myositis and Myopathies

2:30PM-4:00PM: Pain – Basic and Clinical Aspects Oral

2:30PM-4:00PM: Rheumatoid Arthritis – Animal Models

2:30PM-4:00PM: Rheumatoid Arthritis – Clinical Aspects I: Cardiac Comorbidities

2:30PM-4:00PM: Sjögren's Syndrome I: Clinical Assessment and Trial Outcomes

2:30PM-4:00PM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment I

2:30PM-4:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment I: Novel and Current Therapies

2:30PM-4:00PM: Vasculitis I: Clinical Trials and Outcomes

4:30PM-6:00PM: 2017 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lecture

4:30PM-6:00PM: ARHP Clinical Practice/Patient Care/Health Services Research

4:30PM-6:00PM: Biology and Pathology of Bone and Joint

4:30PM-6:00PM: Education

4:30PM-6:00PM: Epidemiology and Public Health II: Non-Genetic Risk Factors for Incident Disease

4:30PM-6:00PM: Healthcare Disparities in Rheumatology

4:30PM-6:00PM: Osteoarthritis – Clinical Aspects I: Pain and Functional Outcomes

4:30PM-6:00PM: Pediatric Rheumatology – Pathogenesis and Genetics

4:30PM-6:00PM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics I

4:30PM-6:00PM: T Cell Biology and Targets in Autoimmune Disease

Monday, November 6, 2017

9:00AM-11:00AM: ARHP Epidemiology and Public Health Poster

9:00AM-11:00AM: ARHP Metabolic and Crystal Arthropathies Poster

9:00AM-11:00AM: ARHP Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: ARHP Rheumatoid Arthritis – Clinical Aspects Poster

9:00AM-11:00AM: ARHP Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster

9:00AM-11:00AM: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster II: Mesenchymal Cells Do React - But How?

9:00AM-11:00AM: Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis

9:00AM-11:00AM: Genetics, Genomics and Proteomics Poster II

9:00AM-11:00AM: Health Services Research Poster II: Osteoarthritis and Rheumatoid Arthritis

9:00AM-11:00AM: Innate Immunity and Rheumatic Disease Poster II

9:00AM-11:00AM: Measures and Measurement of Healthcare Quality Poster I

9:00AM-11:00AM: Metabolic and Crystal Arthropathies Poster I

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

9:00AM-11:00AM: Osteoarthritis – Clinical Aspects Poster I: Clinical Trials and Interventions

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster II

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster II

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster II: Lupus and Related Disorders, Myositis, Scleroderma and Vasculitis

9:00AM-11:00AM: Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Animal Models Poster II

9:00AM-11:00AM: Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures

9:00AM-11:00AM: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports

9:00AM-11:00AM: Sjögren's Syndrome Poster II: Clinical Research

9:00AM-11:00AM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II

9:00AM-11:00AM: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities

9:00AM-11:00AM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster II

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster II

9:00AM-11:00AM: T Cell Biology and Targets in Autoimmune Disease Poster I

9:00AM-11:00AM: Vasculitis Poster II: ANCA-Associated Vasculitis

11:00AM-12:30PM: Plenary Session II

2:30PM-4:00PM: ACR/ARHP Combined: Orthopedics and Rehabilitation Science

2:30PM-4:00PM: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis: Unexpected Effects from "Well-Known" Molecules

2:30PM-4:00PM: Measures and Measurement of Healthcare Quality

2:30PM-4:00PM: Patient Outcomes, Preferences, and Attitudes I

2:30PM-4:00PM: Reproductive Issues in Rheumatic Disorders

2:30PM-4:00PM: Rheumatoid Arthritis – Clinical Aspects II: Treatment Patterns

2:30PM-4:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy I: Outcomes Therapy

2:30PM-4:00PM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment II

2:30PM-4:00PM: Systemic Lupus Erythematosus – Animal Models

2:30PM-4:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment II: Clinical Trial Design and Outcome Measures

2:30PM-4:00PM: Vasculitis II: Biomarkers and Disease Activity

4:30PM-6:00PM: ACR/ARHP Combined: Epidemiology and Public Health: Prevention, Recognition, and Treatment

4:30PM-6:00PM: ARHP Education/Community Programs

4:30PM-6:00PM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

4:30PM-6:00PM: Imaging of Rheumatic Diseases I: Novel Imaging and Scoring Systems

4:30PM-6:00PM: Miscellaneous Rheumatic and Inflammatory Diseases I

4:30PM-6:00PM: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis

4:30PM-6:00PM: Pediatric Rheumatology – Clinical and Therapeutic Aspects I: Autoinflammatory Diseases

4:30PM-6:00PM: Rheumatoid Arthritis – Clinical Aspects III: Obesity and Other Comorbidities

4:30PM-6:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy II: Trials Therapy

4:30PM-6:00PM: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology

4:30PM-6:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment III: Biomarkers

4:30PM-6:00PM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics I

Tuesday, November 7, 2017

9:00AM-11:00AM: ACR Late-Breaking Abstract Poster

9:00AM-11:00AM: ARHP Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

9:00AM-11:00AM: ARHP Imaging of Rheumatic Diseases Poster

9:00AM-11:00AM: ARHP Measures and Measurement of Healthcare Quality Poster

9:00AM-11:00AM: ARHP Osteoarthritis – Clinical Aspects Poster

9:00AM-11:00AM: ARHP Pain – Clinical Aspects Poster

9:00AM-11:00AM: ARHP Patient Outcomes, Attitudes, and Preferences Poster

9:00AM-11:00AM: ARHP Pediatric Rheumatology – Clinical Aspects Poster

9:00AM-11:00AM: ARHP Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster

9:00AM-11:00AM: ARHP Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster

9:00AM-11:00AM: Biology and Pathology of Bone and Joint Poster II

9:00AM-11:00AM: Epidemiology and Public Health Poster III: Rheumatic Disease Risk and Outcomes

9:00AM-11:00AM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster II

9:00AM-11:00AM: Measures and Measurement of Healthcare Quality Poster II

9:00AM-11:00AM: Metabolic and Crystal Arthropathies Poster II

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster II

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster

9:00AM-11:00AM: Osteoarthritis – Clinical Aspects Poster II: Observational and Epidemiological Studies

9:00AM-11:00AM: Pain – Basic and Clinical Aspects Poster

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster III

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster III: Juvenile Arthritis

9:00AM-11:00AM: Pediatric Rheumatology – Pathogenesis and Genetics Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

9:00AM-11:00AM: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster III

9:00AM-11:00AM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster III: Efficacy and Safety of Originator Biologics and Biosimilars

9:00AM-11:00AM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster III: Outcomes, Outcome Measures, and Comorbidities

9:00AM-11:00AM: Systemic Lupus Erythematosus – Animal Models Poster

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster III: Therapeutics and Clinical Trial Design

9:00AM-11:00AM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster III

9:00AM-11:00AM: T Cell Biology and Targets in Autoimmune Disease Poster II

9:00AM-11:00AM: Vasculitis Poster III: Other Vasculitis Syndromes

11:00AM-12:30PM: Plenary Session III

2:30PM-4:00PM: Antiphospholipid Syndrome

2:30PM-4:00PM: ARHP Rehabilitation Science

2:30PM-4:00PM: Innate Immunity and Rheumatic Disease

2:30PM-4:00PM: Patient Outcomes, Preferences, and Attitudes II

2:30PM-4:00PM: Rheumatoid Arthritis – Clinical Aspects IV: Medications and Risk

2:30PM-4:00PM: Rheumatoid Arthritis – Human Etiology and Pathogenesis I

2:30PM-4:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy III: Biosimilars Therapy

2:30PM-4:00PM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment III

2:30PM-4:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment IV: Neuropsychiatric Disease and Health Economics

2:30PM-4:00PM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis I

4:30PM-6:00PM: ACR Late-Breaking Abstract Session

4:30PM-6:00PM: ARHP: Exemplary Abstracts

4:30PM-6:00PM: Genetics, Genomics and Proteomics

4:30PM-6:00PM: Health Services Research I: Cost Drivers in Rheumatic Disease

4:30PM-6:00PM: Infection-related Rheumatic Disease

4:30PM-6:00PM: Metabolic and Crystal Arthropathies I: Gout Risk of Disease Activity, Cardiovascular Disease and Mortality

4:30PM-6:00PM: Orthopedics, Low Back Pain and Rehabilitation

4:30PM-6:00PM: Pediatric Rheumatology – Clinical and Therapeutic Aspects II: Juvenile Arthritis

4:30PM-6:00PM: Rheumatoid Arthritis – Clinical Aspects V: Predicting Treatment Response

4:30PM-6:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy IV: Pharmacodynamic Markers and Therapeutic Intervention

4:30PM-6:00PM: Sjögren's Syndrome II: Pathogenesis, Autoantibodies and T-Cells

4:30PM-6:00PM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment IV

4:30PM-6:00PM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics II

Wednesday, November 8, 2017

9:00AM-10:30AM: ACR/ARHP Combined: Pediatrics

9:00AM-10:30AM: Health Services Research II: Methods and Technology in Care and Research

9:00AM-10:30AM: Metabolic and Crystal Arthropathies II: Mechanisms of Crystal Inflammation and Metabolism

9:00AM-10:30AM: Miscellaneous Rheumatic and Inflammatory Diseases II

9:00AM-10:30AM: Rheumatoid Arthritis – Clinical Aspects VI: Comorbidities of Rheumatoid Arthritis

9:00AM-10:30AM: Rheumatoid Arthritis – Human Etiology and Pathogenesis II

9:00AM-10:30AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment V: Longterm Outcomes

9:00AM-10:30AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics II

9:00AM-10:30AM: Vasculitis III: Pathogenesis

11:00AM-12:30PM: ARHP Epidemiology and Public Health

11:00AM-12:30PM: Imaging of Rheumatic Diseases II: Focus on Rheumatoid Arthritis and Systemic Sclerosis

11:00AM-12:30PM: Osteoarthritis – Clinical Aspects II: Structural Progression and Incidence

11:00AM-12:30PM: Patient Outcomes, Preferences, and Attitudes III

11:00AM-12:30PM: Pediatric Rheumatology – Clinical and Therapeutic Aspects III: Lupus, Dermatomyositis, and Scleroderma

11:00AM-12:30PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy V: Imaging and Cardiovascular Outcomes Therapy

11:00AM-12:30PM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment V

11:00AM-12:30PM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis II

11:00AM-12:30PM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics III

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].